Development Programs
Advancing Novel Treatments for Patients with Muscle Disease
Discovery
Lead Candidate
Nonclinical Development
Clinical Development
Muscular Dystrophy
Cardiomyopathy
Myotonic Dystrophy Type 1
New Hope for Patients with Muscle and Heart Disease
Kate Therapeutics is a privately-held company with experienced leadership, a world-class scientific advisory team, and leading investor partners.